Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Neurology India|January 14, 2017
Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletionTrupti Pai, Sridhar Epari, Sangeeta Desai, et al.
Nanoscale|October 8, 2021
Ultrasound augments on-demand breast tumor radiosensitization and apoptosis through a tri-responsive combinatorial delivery theranostic platformPrateek Bhardwaj, Jayant Sastri Goda, Venkatesh Pai, et al.
Journal of Pathology Informatics|October 10, 2025
Digital pathology enabling lean management of HER2/neu testing in breast CancerAishwarya Sharma, Prarthna Shah, Manali Ranade, et al.
Clinical Breast Cancer|May 30, 2020
Identification of Luminal Subtypes of Breast Carcinoma Using Surrogate Immunohistochemical Markers and Ascertaining Their Prognostic RelevanceAkash P Sali, Nishtha Sharma, Anuj Verma, et al.
Journal of Clinical Pathology|May 26, 2026
Concordance of conventional two-tier HER2 classification versus three-tier classification (including HER2-low status) in invasive breast carcinoma: a retrospective real-world analysisArchita Juneja, Ayushi Sahay, Pooja Padwale, et al.
Ecancermedicalscience|June 10, 2025
Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in IndiaMehak Trikha, Vanita Noronha, Minit Shah, et al.
Ecancermedicalscience|March 1, 2024
Clinical outcomes of <i>ROS1</i>-positive non-small cell lung cancer with limited access to <i>ROS1</i>-tyrosine kinase inhibitors (TKIs): experience from an Indian tertiary referral centreGoutam Santosh Panda, Vanita Noronha, Vijay Patil, et al.
The Journal of Pathology. Clinical Research|February 9, 2018
Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancersAnita Grigoriadis, Patrycja Gazinska, Trupti Pai, et al.
Neurology India|January 13, 2016
Epidermal growth factor receptor (EGFR) gene amplification in high-grade gliomas: Western Indian tertiary cancer center experienceDivya Shelly, Sridhar Epari, Iteeka Arora, et al.
BJC Reports|November 8, 2024
Lorlatinib in the second line and beyond for ALK positive lung cancer: real-world data from resource-constrained settingsAmit Kumar, Akhil Kapoor, Vanita Noronha, et al.
Pageof 6